Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 | 2024 | 1560 | 1.260 |
Why?
|
Fluorocarbons | 5 | 2023 | 506 | 1.170 |
Why?
|
Prenatal Exposure Delayed Effects | 6 | 2021 | 2538 | 1.110 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 230 | 1.040 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2023 | 384 | 0.890 |
Why?
|
Environmental Pollutants | 4 | 2023 | 1296 | 0.840 |
Why?
|
Alkanesulfonic Acids | 3 | 2023 | 203 | 0.830 |
Why?
|
Leukemia, Biphenotypic, Acute | 2 | 2019 | 32 | 0.810 |
Why?
|
Leukemia | 6 | 2021 | 1519 | 0.740 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2024 | 1613 | 0.700 |
Why?
|
Fibrosarcoma | 2 | 2020 | 313 | 0.660 |
Why?
|
Environmental Exposure | 5 | 2023 | 4543 | 0.630 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1146 | 0.600 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 25 | 0.590 |
Why?
|
Air Pollutants | 3 | 2023 | 2916 | 0.460 |
Why?
|
Executive Function | 3 | 2021 | 1401 | 0.460 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1738 | 0.440 |
Why?
|
Vehicle Emissions | 2 | 2016 | 651 | 0.440 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1027 | 0.400 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1074 | 0.400 |
Why?
|
Cognition | 3 | 2018 | 7073 | 0.360 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2024 | 228 | 0.350 |
Why?
|
Child | 41 | 2024 | 80917 | 0.340 |
Why?
|
Sequence Analysis, RNA | 4 | 2023 | 2040 | 0.340 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3626 | 0.340 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2024 | 3671 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 7 | 2005 | 1406 | 0.330 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 234 | 0.310 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3445 | 0.300 |
Why?
|
Genomics | 5 | 2023 | 5926 | 0.280 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 3 | 2022 | 308 | 0.280 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1164 | 0.280 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2022 | 701 | 0.270 |
Why?
|
Neoplasms | 7 | 2024 | 22371 | 0.260 |
Why?
|
Neoplasm, Residual | 3 | 2020 | 1015 | 0.260 |
Why?
|
Translocation, Genetic | 3 | 2024 | 1394 | 0.260 |
Why?
|
Intracellular Membranes | 3 | 2003 | 388 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9419 | 0.250 |
Why?
|
Child, Preschool | 23 | 2024 | 42669 | 0.250 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2414 | 0.240 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4282 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 7 | 2024 | 4528 | 0.230 |
Why?
|
Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2021 | 2521 | 0.220 |
Why?
|
Oxidative Phosphorylation | 4 | 2008 | 501 | 0.210 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 144 | 0.200 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2024 | 249 | 0.200 |
Why?
|
Infant | 19 | 2022 | 36535 | 0.200 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1907 | 0.200 |
Why?
|
Mitochondria | 7 | 2005 | 3681 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2018 | 2846 | 0.190 |
Why?
|
Lentivirus | 1 | 2024 | 518 | 0.190 |
Why?
|
Asparaginase | 3 | 2021 | 240 | 0.190 |
Why?
|
Myelodysplastic Syndromes | 3 | 2024 | 1399 | 0.190 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 42 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 313 | 0.190 |
Why?
|
Medical Oncology | 1 | 2013 | 2346 | 0.180 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 72 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2021 | 2982 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 183 | 0.180 |
Why?
|
Blood Group Antigens | 1 | 2022 | 183 | 0.180 |
Why?
|
Humans | 69 | 2024 | 768166 | 0.170 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1351 | 0.170 |
Why?
|
Air Pollution | 2 | 2023 | 2374 | 0.170 |
Why?
|
Ikaros Transcription Factor | 2 | 2018 | 233 | 0.170 |
Why?
|
Pregnancy | 9 | 2023 | 30256 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 45 | 0.160 |
Why?
|
Tissue Banks | 2 | 2020 | 183 | 0.160 |
Why?
|
Mutation | 13 | 2023 | 30238 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 658 | 0.160 |
Why?
|
Remission Induction | 3 | 2020 | 2410 | 0.160 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 148 | 0.160 |
Why?
|
Fasciitis | 1 | 2019 | 66 | 0.160 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 571 | 0.160 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 183 | 0.160 |
Why?
|
Pyruvate Kinase | 2 | 2012 | 191 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11878 | 0.150 |
Why?
|
Protein Isoforms | 1 | 2023 | 1715 | 0.150 |
Why?
|
Galectins | 1 | 2021 | 295 | 0.150 |
Why?
|
Gene Duplication | 2 | 2022 | 315 | 0.150 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 158 | 0.150 |
Why?
|
Pediatrics | 1 | 2013 | 3629 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 354 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 375 | 0.140 |
Why?
|
Interleukin-3 | 6 | 2005 | 425 | 0.140 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 308 | 0.140 |
Why?
|
Polyethylene Glycols | 3 | 2021 | 1196 | 0.140 |
Why?
|
Adolescent | 20 | 2024 | 89169 | 0.140 |
Why?
|
Mothers | 2 | 2018 | 2209 | 0.140 |
Why?
|
Scalp | 1 | 2019 | 391 | 0.140 |
Why?
|
Glycolysis | 7 | 2008 | 837 | 0.130 |
Why?
|
Sequence Deletion | 3 | 2018 | 1497 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 465 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2019 | 329 | 0.130 |
Why?
|
Proteins | 2 | 2010 | 6009 | 0.130 |
Why?
|
Female | 37 | 2024 | 397192 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 708 | 0.130 |
Why?
|
Apoptosis | 8 | 2005 | 9523 | 0.120 |
Why?
|
Genetic Testing | 2 | 2019 | 3591 | 0.120 |
Why?
|
Pesticides | 1 | 2018 | 298 | 0.120 |
Why?
|
Linear Models | 4 | 2018 | 5884 | 0.120 |
Why?
|
Skull | 1 | 2019 | 820 | 0.120 |
Why?
|
Gene Fusion | 1 | 2018 | 356 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2024 | 2433 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1778 | 0.120 |
Why?
|
Genetic Vectors | 1 | 2024 | 3402 | 0.120 |
Why?
|
Male | 39 | 2024 | 364719 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 802 | 0.120 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 2048 | 0.120 |
Why?
|
Oncogenes | 3 | 2021 | 1234 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 378 | 0.110 |
Why?
|
Environmental Monitoring | 2 | 2023 | 1469 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 771 | 0.110 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 231 | 0.100 |
Why?
|
Carbon | 2 | 2015 | 673 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2013 | 159 | 0.100 |
Why?
|
Enzyme Activators | 1 | 2012 | 56 | 0.100 |
Why?
|
Transplants | 1 | 2015 | 208 | 0.100 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 737 | 0.100 |
Why?
|
Breast Feeding | 2 | 2023 | 1363 | 0.100 |
Why?
|
Exons | 4 | 2023 | 2394 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3611 | 0.100 |
Why?
|
Lymphoma, Follicular | 1 | 2016 | 460 | 0.100 |
Why?
|
Biopolymers | 1 | 2012 | 183 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2022 | 26422 | 0.100 |
Why?
|
Fetal Blood | 1 | 2018 | 1361 | 0.090 |
Why?
|
Esophageal Perforation | 1 | 2011 | 65 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 528 | 0.090 |
Why?
|
Pregnancy Trimester, First | 1 | 2015 | 917 | 0.090 |
Why?
|
Treatment Failure | 2 | 2014 | 2661 | 0.090 |
Why?
|
Cell Proliferation | 5 | 2014 | 10474 | 0.090 |
Why?
|
Genes, Fungal | 2 | 2002 | 440 | 0.080 |
Why?
|
Child Behavior | 1 | 2016 | 864 | 0.080 |
Why?
|
Down Syndrome | 1 | 2018 | 919 | 0.080 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 168 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2015 | 863 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2540 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 1000 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1494 | 0.080 |
Why?
|
Chromosome Segregation | 1 | 2010 | 230 | 0.080 |
Why?
|
Centrosome | 1 | 2010 | 210 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1883 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1058 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 617 | 0.080 |
Why?
|
Particulate Matter | 2 | 2023 | 2617 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2118 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 4 | 2005 | 281 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 998 | 0.080 |
Why?
|
Young Adult | 10 | 2022 | 60066 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2021 | 9118 | 0.070 |
Why?
|
Glucose | 5 | 2004 | 4352 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2957 | 0.070 |
Why?
|
Intestinal Perforation | 1 | 2010 | 254 | 0.070 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2010 | 210 | 0.070 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3833 | 0.070 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 314 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11095 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26379 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2565 | 0.070 |
Why?
|
Growth Substances | 3 | 2005 | 759 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1898 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2810 | 0.070 |
Why?
|
Natural Killer T-Cells | 1 | 2010 | 318 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4428 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2909 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2332 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39348 | 0.060 |
Why?
|
Mice | 19 | 2023 | 82029 | 0.060 |
Why?
|
Granulocytes | 1 | 2008 | 551 | 0.060 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 4786 | 0.060 |
Why?
|
Adult | 12 | 2024 | 223646 | 0.060 |
Why?
|
Signal Transduction | 5 | 2024 | 23645 | 0.060 |
Why?
|
Stem Cells | 3 | 2010 | 3537 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2020 | 879 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12795 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3463 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2935 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3428 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5804 | 0.060 |
Why?
|
Molecular Targeted Therapy | 3 | 2022 | 2830 | 0.060 |
Why?
|
Prognosis | 6 | 2021 | 30010 | 0.060 |
Why?
|
Syndrome | 1 | 2010 | 3272 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2016 | 2014 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12168 | 0.060 |
Why?
|
Child Development | 1 | 2016 | 2330 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2945 | 0.060 |
Why?
|
Animals | 22 | 2023 | 169246 | 0.060 |
Why?
|
Environmental Policy | 1 | 2023 | 36 | 0.060 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2003 | 22 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 146 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13676 | 0.050 |
Why?
|
Histones | 1 | 2014 | 2601 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1837 | 0.050 |
Why?
|
Receptor, trkA | 1 | 2024 | 159 | 0.050 |
Why?
|
Escherichia coli | 1 | 2015 | 4214 | 0.050 |
Why?
|
MicroRNAs | 2 | 2010 | 3803 | 0.050 |
Why?
|
Climate | 1 | 2023 | 146 | 0.050 |
Why?
|
Cohort Studies | 4 | 2021 | 41754 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2008 | 1105 | 0.050 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10266 | 0.050 |
Why?
|
Cytochromes c | 1 | 2003 | 173 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2023 | 125 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1864 | 0.050 |
Why?
|
Alleles | 3 | 2022 | 6894 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4206 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8890 | 0.050 |
Why?
|
Oxygen Consumption | 3 | 2008 | 1880 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.050 |
Why?
|
Research Design | 2 | 2016 | 6211 | 0.050 |
Why?
|
Lactation | 1 | 2023 | 392 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3533 | 0.040 |
Why?
|
United States | 5 | 2023 | 73039 | 0.040 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2000 | 15 | 0.040 |
Why?
|
Survival Analysis | 3 | 2019 | 10101 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4793 | 0.040 |
Why?
|
Nitrogen Dioxide | 1 | 2023 | 534 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2682 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 430 | 0.040 |
Why?
|
Porins | 1 | 2000 | 78 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2020 | 84 | 0.040 |
Why?
|
Cytosol | 1 | 2003 | 887 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2892 | 0.040 |
Why?
|
Codon | 1 | 2021 | 599 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 17140 | 0.040 |
Why?
|
Electron Transport | 1 | 2000 | 211 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8509 | 0.040 |
Why?
|
Age Factors | 4 | 2018 | 18412 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 2000 | 375 | 0.040 |
Why?
|
Prospective Studies | 3 | 2022 | 54926 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 354 | 0.040 |
Why?
|
DNA Primers | 2 | 2014 | 2828 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59629 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2019 | 334 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4413 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2004 | 1895 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2019 | 476 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10399 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8054 | 0.030 |
Why?
|
Agriculture | 1 | 2018 | 186 | 0.030 |
Why?
|
Autophagy | 1 | 2005 | 1349 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 24315 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12840 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6847 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 593 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1683 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6526 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2614 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1627 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2131 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 474 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 755 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Biological Transport | 1 | 2000 | 2085 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1040 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2000 | 877 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 899 | 0.030 |
Why?
|
Cell Survival | 3 | 2001 | 5777 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 504 | 0.030 |
Why?
|
Sulfonic Acids | 1 | 2015 | 103 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 371 | 0.030 |
Why?
|
bcl-X Protein | 3 | 2002 | 412 | 0.030 |
Why?
|
Cell Division | 4 | 2004 | 4473 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5703 | 0.030 |
Why?
|
Caprylates | 1 | 2015 | 115 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1197 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 416 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1103 | 0.030 |
Why?
|
Aerobiosis | 2 | 2004 | 100 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 354 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13671 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2015 | 556 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1609 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9374 | 0.030 |
Why?
|
California | 1 | 2018 | 1438 | 0.030 |
Why?
|
Ethanol | 1 | 2000 | 1331 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 229 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 362 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 714 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6124 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1567 | 0.030 |
Why?
|
Pyruvic Acid | 2 | 2008 | 205 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1737 | 0.030 |
Why?
|
Aged | 4 | 2021 | 171504 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1219 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 13014 | 0.030 |
Why?
|
Phenotype | 4 | 2016 | 16726 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15832 | 0.030 |
Why?
|
Maternal Age | 1 | 2015 | 805 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2720 | 0.030 |
Why?
|
Parity | 1 | 2015 | 931 | 0.020 |
Why?
|
Gene Frequency | 1 | 2019 | 3623 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2024 | 2062 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1674 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 16045 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2396 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1078 | 0.020 |
Why?
|
Doxorubicin | 1 | 2018 | 2234 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12421 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3740 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 22379 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 2 | 2002 | 186 | 0.020 |
Why?
|
Protein Kinases | 1 | 2018 | 1611 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 74944 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2603 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6514 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5863 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 492 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21206 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3343 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2130 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10760 | 0.020 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2002 | 437 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5315 | 0.020 |
Why?
|
Adenosine Diphosphate | 2 | 2002 | 422 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2011 | 398 | 0.020 |
Why?
|
Skin Diseases, Bacterial | 1 | 2010 | 65 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1410 | 0.020 |
Why?
|
Social Behavior | 1 | 2016 | 1147 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2010 | 365 | 0.020 |
Why?
|
Glioblastoma | 1 | 2004 | 3464 | 0.020 |
Why?
|
Neurons | 2 | 2010 | 9514 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2062 | 0.020 |
Why?
|
Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 269 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6793 | 0.020 |
Why?
|
Cell Line | 4 | 2003 | 15597 | 0.020 |
Why?
|
Myogenic Regulatory Factors | 1 | 2008 | 102 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 2010 | 250 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2014 | 19015 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1754 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2575 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7876 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 3035 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9615 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4852 | 0.020 |
Why?
|
Microcephaly | 1 | 2010 | 426 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2709 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9561 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2008 | 14488 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1890 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5341 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2554 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 65371 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5027 | 0.020 |
Why?
|
Mitosis | 1 | 2010 | 1178 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12077 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2005 | 240 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2004 | 2457 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2010 | 1082 | 0.010 |
Why?
|
Cycloheximide | 1 | 2004 | 341 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2020 | 81762 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3603 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40218 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3110 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2767 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2004 | 2885 | 0.010 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2003 | 71 | 0.010 |
Why?
|
Neurogenesis | 1 | 2010 | 864 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6082 | 0.010 |
Why?
|
Rotenone | 1 | 2003 | 50 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2000 | 2004 | 0.010 |
Why?
|
Succinates | 1 | 2003 | 83 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20227 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 687 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2004 | 866 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2003 | 142 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5797 | 0.010 |
Why?
|
Lactic Acid | 1 | 2008 | 1140 | 0.010 |
Why?
|
Cell Respiration | 1 | 2003 | 201 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7243 | 0.010 |
Why?
|
Fermentation | 1 | 2002 | 143 | 0.010 |
Why?
|
Binding Sites | 2 | 2002 | 6020 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6231 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2003 | 5902 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7852 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3623 | 0.010 |
Why?
|
RNA, Viral | 1 | 2010 | 2872 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17622 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12543 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 921 | 0.010 |
Why?
|
Anemia | 1 | 2010 | 1514 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2000 | 2568 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2675 | 0.010 |
Why?
|
Cells | 1 | 2001 | 166 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5717 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 1090 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2002 | 694 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9538 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2560 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1832 | 0.010 |
Why?
|
S Phase | 1 | 2000 | 424 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4035 | 0.010 |
Why?
|
Lysosomes | 1 | 2005 | 938 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2002 | 1216 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22291 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11669 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 626 | 0.010 |
Why?
|
Interphase | 1 | 1999 | 227 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15454 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3590 | 0.010 |
Why?
|
Dimerization | 1 | 1999 | 887 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2002 | 762 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1379 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2000 | 567 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11244 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5755 | 0.010 |
Why?
|
Cerebellum | 1 | 2003 | 1522 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2234 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1646 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12800 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3786 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7577 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6669 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13490 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3284 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1839 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3772 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8647 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4415 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5505 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 4354 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2000 | 2429 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3348 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18349 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2000 | 2907 | 0.010 |
Why?
|
Lung | 1 | 2008 | 10099 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10873 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20760 | 0.000 |
Why?
|
Gene Expression | 1 | 2000 | 7598 | 0.000 |
Why?
|
Protein Binding | 1 | 1999 | 9343 | 0.000 |
Why?
|
Cytokines | 1 | 1999 | 7453 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13586 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9495 | 0.000 |
Why?
|